FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...